Know more

Our use of cookies

Cookies are a set of data stored on a user’s device when the user browses a web site. The data is in a file containing an ID number, the name of the server which deposited it and, in some cases, an expiry date. We use cookies to record information about your visit, language of preference, and other parameters on the site in order to optimise your next visit and make the site even more useful to you.

To improve your experience, we use cookies to store certain browsing information and provide secure navigation, and to collect statistics with a view to improve the site’s features. For a complete list of the cookies we use, download “Ghostery”, a free plug-in for browsers which can detect, and, in some cases, block cookies.

Ghostery is available here for free: https://www.ghostery.com/fr/products/

You can also visit the CNIL web site for instructions on how to configure your browser to manage cookie storage on your device.

In the case of third-party advertising cookies, you can also visit the following site: http://www.youronlinechoices.com/fr/controler-ses-cookies/, offered by digital advertising professionals within the European Digital Advertising Alliance (EDAA). From the site, you can deny or accept the cookies used by advertising professionals who are members.

It is also possible to block certain third-party cookies directly via publishers:

Cookie type

Means of blocking

Analytical and performance cookies

Realytics
Google Analytics
Spoteffects
Optimizely

Targeted advertising cookies

DoubleClick
Mediarithmics

The following types of cookies may be used on our websites:

Mandatory cookies

Functional cookies

Social media and advertising cookies

These cookies are needed to ensure the proper functioning of the site and cannot be disabled. They help ensure a secure connection and the basic availability of our website.

These cookies allow us to analyse site use in order to measure and optimise performance. They allow us to store your sign-in information and display the different components of our website in a more coherent way.

These cookies are used by advertising agencies such as Google and by social media sites such as LinkedIn and Facebook. Among other things, they allow pages to be shared on social media, the posting of comments, and the publication (on our site or elsewhere) of ads that reflect your centres of interest.

Our EZPublish content management system (CMS) uses CAS and PHP session cookies and the New Relic cookie for monitoring purposes (IP, response times).

These cookies are deleted at the end of the browsing session (when you log off or close your browser window)

Our EZPublish content management system (CMS) uses the XiTi cookie to measure traffic. Our service provider is AT Internet. This company stores data (IPs, date and time of access, length of the visit and pages viewed) for six months.

Our EZPublish content management system (CMS) does not use this type of cookie.

For more information about the cookies we use, contact INRA’s Data Protection Officer by email at cil-dpo@inra.fr or by post at:

INRA
24, chemin de Borde Rouge –Auzeville – CS52627
31326 Castanet Tolosan CEDEX - France

Dernière mise à jour : Mai 2018

Menu INRA Oniris FSEV

Congrès FSEV 2019 - French Society of Extracellular Vesicles

Welcome

2nd FSEV congress

Extracellular Vesicles in Health & Disease

14-15 October 2019

Early bird & abstract submission deadline closes June 15, 2019!

The 2nd Congress of the French Society of Extracellular Vesicles (FSEV) will be held in Nantes, France on 14-15 October 2019. This event will focus on the role of extracellular vesicles in health & disease. With 200 attendees at the 1rst congress in 2017, this is the perfect occasion to meet basic scientists, clinicians and industrial professionals active in the EV field from France and neighboring countries. Want to learn more? Subscribe to news for upcoming information on sessions & keynote speakers. We are very pleased to welcome you to this event!

___________________________

La Société Française de Vésicules Extracellulaires (FSEV) a plaisir de vous inviter à son 2e congrès à Nantes le 14-15 octobre 2019. Cet événement sera consacré aux aspects fondamentaux et cliniques des vésicules extracellulaires. Avec 200 participants à la première édition en 2017, ce rassemblement sera l’occasion parfaite de rencontre des chercheurs, cliniciens et industriels du domaine venus de France et des pays limitrophes. Abonnez-vous à cette page pour apprendre plus sur les sessions & orateurs !

Keynote speakers :

Chantal Boulanger 1

Chantal M. Boulanger, PhD, obtained her PhD in Pharmacology at the University of Strasbourg and spent her research fellowships at the Mayo Clinic, Rochester, MN and in Basel, Switzerland. She was appointed Assistant Professor at Baylor College Medicine in Houston in 1991. She joined the French National Health and Medical Research Institute (INSERM) in 1995 as Director or Research. She has been leading an INSERM team on extracellular vesicles in cardiovascular diseases since 2004. She has co-authored over 160 peer-reviewed publications and 17 books or book chapters and has been acting as an Associate Editor of Arteriosclerosis Thrombosis and Vascular Biology since 2010 and Journal Extracellular Vesicles since 2018. She is currently the Director of the Paris-Cardiovascular Research Center http://cvscience.aviesan.fr/cv/27/chantal-boulanger.

An Hendrix

An Hendrix is assistant professor at Ghent University and group leader at the Cancer Research Institute Ghent (CRIG) (https://www.crig.ugent.be/en/prof-an-hendrix-phd). Her team studies small Rab GTPase-mediated release of extracellular vesicles (EV) by tumors, and the isolation and characterization of these nanometer-sized vesicles from liquid biopsies (PMID:30518529; PMID:28245209; PMID:25317274, PMID:20484105). To allow and boost the clinical implementation of EV in daily practice An Hendrix significantly invested in standardization and reproducibility of EV research since this is the foremost important step to initiate biomarker discovery. She is founder of the EV-TRACK consortium that aims to increase transparent reporting and reproducibility in EV research (www.evtrack.org). She yearly organizes the EMBO/EMBL hands-on course on EV (Heidelberg, Germany: https://www.embl.de/training/events/2019/EXO19-01/) and is founder of the Belgian Society for Extracellular Vesicles that connects Belgian scientists working on EV (www.besev.be).

Eric Oswald

Pr Eric Oswald is the head of the laboratory of bacteriology at the university hospital of Toulouse and the deputy director of the Digestive Health Research Institute (IRSD ; https://www.irsd.fr/). E. Oswald has 160 peer-reviewed international publications (H Factor 45). He is an expert in cellular microbiology and molecular biology of pathogenic Escherichia coli. His highly productive, multidisciplinary and cooperative team is currently consisting of twenty people. Several of the publications generated by this group represent milestones in the understanding of bacterial pathogenicity especially the discovery of new toxins and secretion systems including the production of Outer Membrane Vesicles (OMV).